These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
408 related articles for article (PubMed ID: 35965504)
21. Stroma Involvement in Pancreatic Ductal Adenocarcinoma: An Overview Focusing on Extracellular Matrix Proteins. Liot S; Balas J; Aubert A; Prigent L; Mercier-Gouy P; Verrier B; Bertolino P; Hennino A; Valcourt U; Lambert E Front Immunol; 2021; 12():612271. PubMed ID: 33889150 [TBL] [Abstract][Full Text] [Related]
22. Deciphering the Prognostic Implications of the Components and Signatures in the Immune Microenvironment of Pancreatic Ductal Adenocarcinoma. Tang R; Liu X; Liang C; Hua J; Xu J; Wang W; Meng Q; Liu J; Zhang B; Yu X; Shi S Front Immunol; 2021; 12():648917. PubMed ID: 33777046 [No Abstract] [Full Text] [Related]
23. Role of STAT3 in pancreatic cancer. Hamel Z; Sanchez S; Standing D; Anant S Explor Target Antitumor Ther; 2024; 5(5):20-34. PubMed ID: 38464736 [TBL] [Abstract][Full Text] [Related]
24. [Pancreatic ductal adenocarcinoma immune microenvironment and immunotherapy prospects]. Ye C; Zheng L; Yuan CH Zhonghua Wai Ke Za Zhi; 2019 Jan; 57(1):10-15. PubMed ID: 30612387 [TBL] [Abstract][Full Text] [Related]
25. Envisioning the immune system to determine its role in pancreatic ductal adenocarcinoma: Culprit or victim? Javadrashid D; Baghbanzadeh A; Hemmat N; Hajiasgharzadeh K; Nourbakhsh NS; Lotfi Z; Baradaran B Immunol Lett; 2021 Apr; 232():48-59. PubMed ID: 33647329 [TBL] [Abstract][Full Text] [Related]
26. Of immune checkpoint maladies and remedies: The throwing of jabs in the oncogenic ring of PDAC. Olaoba OT; Ligali FC; Alabi ZO; Akinyemi AO; Ayinde KS Biochim Biophys Acta Rev Cancer; 2021 Jan; 1875(1):188483. PubMed ID: 33232723 [TBL] [Abstract][Full Text] [Related]
27. Combination, Modulation and Interplay of Modern Radiotherapy with the Tumor Microenvironment and Targeted Therapies in Pancreatic Cancer: Which Candidates to Boost Radiotherapy? Benkhaled S; Peters C; Jullian N; Arsenijevic T; Navez J; Van Gestel D; Moretti L; Van Laethem JL; Bouchart C Cancers (Basel); 2023 Jan; 15(3):. PubMed ID: 36765726 [TBL] [Abstract][Full Text] [Related]
28. The tumor microenvironment in pancreatic ductal adenocarcinoma: current perspectives and future directions. Herting CJ; Karpovsky I; Lesinski GB Cancer Metastasis Rev; 2021 Sep; 40(3):675-689. PubMed ID: 34591240 [TBL] [Abstract][Full Text] [Related]
29. Extracellular vesicle-mediated crosstalk between pancreatic cancer and stromal cells in the tumor microenvironment. Li Y; Zhao W; Wang Y; Wang H; Liu S J Nanobiotechnology; 2022 May; 20(1):208. PubMed ID: 35501802 [TBL] [Abstract][Full Text] [Related]
30. Disruption of Cell-Cell Communication in Anaplastic Thyroid Cancer as an Immunotherapeutic Opportunity. Chakraborty S; Carnazza M; Jarboe T; DeSouza N; Li XM; Moscatello A; Geliebter J; Tiwari RK Adv Exp Med Biol; 2021; 1350():33-66. PubMed ID: 34888843 [TBL] [Abstract][Full Text] [Related]
36. Local and systemic immune profiles of human pancreatic ductal adenocarcinoma revealed by single-cell mass cytometry. Brouwer TP; de Vries NL; Abdelaal T; Krog RT; Li Z; Ruano D; Fariña A; Lelieveldt BPF; Morreau H; Bonsing BA; Vahrmeijer AL; Koning F; de Miranda NFCC J Immunother Cancer; 2022 Jul; 10(7):. PubMed ID: 35793870 [TBL] [Abstract][Full Text] [Related]
38. Pancreatic Cancer and Cellular Senescence: Tumor Microenvironment under the Spotlight. Cortesi M; Zanoni M; Pirini F; Tumedei MM; Ravaioli S; Rapposelli IG; Frassineti GL; Bravaccini S Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008679 [TBL] [Abstract][Full Text] [Related]
39. Local and systemic immunosuppression in pancreatic cancer: Targeting the stalwarts in tumor's arsenal. Mundry CS; Eberle KC; Singh PK; Hollingsworth MA; Mehla K Biochim Biophys Acta Rev Cancer; 2020 Aug; 1874(1):188387. PubMed ID: 32579889 [TBL] [Abstract][Full Text] [Related]
40. The Potential of Induced Pluripotent Stem Cells to Advance the Treatment of Pancreatic Ductal Adenocarcinoma. Krog RT; de Miranda NFCC; Vahrmeijer AL; Kooreman NG Cancers (Basel); 2021 Nov; 13(22):. PubMed ID: 34830945 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]